OMCL - Omnicell, Inc.
NEXT EARNINGS:
May 5, 2026
EPS Est: $0.33
Price:
--
--
|
CONSENSUS:
Hold
DETAILS
|
PRICE TARGET:
$53.50
DETAILS
HIGH:
$60.00
LOW:
$49.00
MEDIAN:
$52.50
CONSENSUS:
$53.50
UPSIDE:
33.25%
Market Cap:
1.84B
Volume:
575,003
Avg Volume:
768,605
52 Week Range:
22.66-55
Sector:
Healthcare
Industry:
Medical - Healthcare Information Services
Beta:
0.77
Last Dividend:
$N/A
Exchange:
NASDAQ
Country:
US
Employees:
3,620
IPO Date:
2001-08-09
EPS (TTM):
0.04
P/E Ratio:
1014.72
Revenue (TTM):
1.18B
Total Assets:
1.97B
Total Debt:
217.18M
Cash & Equiv:
196.52M
Rev Growth (5Y):
5.8%
EPS Growth (5Y):
-43.3%
FCF Growth (5Y):
-7.9%
ROCE:
0.8%
Debt/Equity:
0.18
Earnings History
| Date | EPS Actual | EPS Est | EPS Surprise | Rev Actual | Rev Est | Rev Surprise |
|---|---|---|---|---|---|---|
| 2026-02-05 | $0.40 | $0.47 | -14.9% | $314.0M | $304.0M | +3.3% |
| 2025-10-30 | $0.51 | $0.36 | +41.7% | $310.6M | $313.4M | -0.9% |
| 2025-07-31 | $0.45 | $0.31 | +45.2% | $290.6M | $292.1M | -0.5% |
| 2025-05-06 | $0.26 | $0.16 | +62.5% | $269.7M | $278.1M | -3.0% |
| 2025-02-06 | $0.60 | $0.57 | +5.3% | $306.9M | $297.9M | +3.0% |
| 2024-10-30 | $0.56 | $0.41 | +36.6% | $282.4M | $297.9M | -5.2% |
| 2024-08-01 | $0.51 | $0.16 | +218.8% | $276.8M | $255.2M | +8.5% |
| 2024-05-02 | $0.03 | $-0.08 | +137.5% | $246.2M | $236.8M | +4.0% |
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 1.18B | 1.11B | 1.15B | 1.30B | 1.13B | 892.21M | 897.03M | 787.31M | 716.16M | 692.62M | 484.56M | 440.90M |
| Net Income | 2.05M | 12.53M | (20.37M) | 5.65M | 77.85M | 32.19M | 61.34M | 37.73M | 20.61M | 603,000 | 30.76M | 30.52M |
| EPS | 0.04 | 0.27 | -0.45 | 0.13 | 1.79 | 0.76 | 1.48 | 0.96 | 0.81 | 0.27 | 0.86 | 0.86 |
| Total Assets | 1.97B | 2.12B | 2.23B | 2.21B | 2.14B | 1.82B | 1.24B | 1.08B | 980.30M | 935.10M | 578.75M | 560.21M |
| Total Debt | 217.18M | 382.55M | 614.09M | 616.74M | 541.01M | 528.29M | 110.73M | 135.42M | 210.12M | 254.14M | 0 | 0 |
| Cash & Equivalents | 196.52M | 369.20M | 467.97M | 330.36M | 349.05M | 485.93M | 127.21M | 67.19M | 32.42M | 54.49M | 82.22M | 125.89M |
| Operating Cash Flow | 127.30M | 187.72M | 181.09M | 77.78M | 231.81M | 185.87M | 145.01M | 103.97M | 24.83M | 47.94M | 33.76M | 65.16M |
| Free Cash Flow | 86.89M | 151.26M | 139.62M | 17.04M | 202.84M | 131.00M | 83.34M | 49.59M | (5.71M) | 18.77M | 13.67M | 42.56M |
| FCF per Share | 1.89 | 3.28 | 3.09 | 0.38 | 4.67 | 3.08 | 2.01 | 1.26 | -0.15 | 0.52 | 0.38 | 1.19 |
| Book Value | 1.23B | 1.24B | 1.19B | 1.13B | 1.15B | 967.50M | 845.25M | 679.62M | 517.20M | 431.61M | 402.39M | 390.10M |
| Cash & ST Investments | 196.52M | 381.68M | 467.97M | 341.85M | 359.72M | 496.17M | 136.98M | 67.19M | 32.42M | 54.49M | 82.22M | 125.89M |
| ROC Equity | 0.00 | 0.01 | -0.02 | 0.00 | 0.07 | 0.03 | 0.07 | 0.06 | 0.04 | 0.00 | 0.08 | 0.08 |